LGC Maine Standards announces VALIDATE® Diabetes kit for Roche cobas® with beta-hydroxybutyrate, C-peptide, Fructosamine, and Insulin for easy, fast, and reliable documentation of linearity, calibration verification, and Analytical Measurement Range (AMR) verification

CUMBERLAND FORESIDE, Maine, Dec. 22, 2020 /PRNewswire/ -- LGC Maine Standards¹ announces the release of VALIDATE^® Diabetes to meet the linearity and calibration verification needs of clinical laboratories running the Roche cobas^® platform. The product (Order No. 204RO), which includes the analytes, beta-hydroxybutyrate, C-peptide, Fructosamine, and Insulin, is formulated in a human serum matrix, using the CLSI EP06-A "equal delta" sample preparation method, and provides five distinct concentrations across the claimed range of the Roche cobas^® instrument. VALIDATE^® Diabetes test kits are liquid and ready-to-use; simply dispense the solution from each dropper bottle, directly into five sample cups, and run in replicates to verify the assay's reportable range.

When combined with Glucose in VALIDATE^® GC1 (1100ro), Micro-Albumin in VALIDATE^® UC5 (705ro), HbA1c in VALIDATE^® HbA1c (605), and HDL and LDL in VALIDATE® LP (501ro), laboratories can challenge the reportable range of Roche cobas^® Diabetes-related assays.

VALIDATE^® Diabetes is FDA listed and offers 5 Levels of complete reportable range coverage – eliminating the need for manual dilutions! VALIDATE^® products allow clinical laboratories to complete their required linearity and calibration verification, maximizing the reportable range while minimizing manual dilutions. Use of this product, while augmenting daily QC, assists with fulfilling various quality control requirements – such as Analytical Measurement Range (AMR) and Reportable Range – for linearity and calibration verification under CLIA '88, CAP, COLA, JCAHO, JCI, and ISO 15189.

The addition of VALIDATE^® Diabetes to LGC Maine Standards' expanding portfolio of products demonstrates a continued commitment to manufacture high-quality linearity and calibration verification products that meet industry needs.

LGC Maine Standards is located in Cumberland Foreside, Maine and manufactures VALIDATE^® linearity and calibration verification kits for over 140 analytes, including General Chemistries, ACTH, Anemia, Body Fluids, Bone, Cardiac, Diabetes, Fertility, Hemostasis, Osmolality, POC, Sepsis, Serum Proteins, Therapeutic Drug Monitoring, Thyroid, Tumor Markers, and Urine Chemistry.

LGC Maine Standards MSDRx^® data reduction software is available at no charge for real-time data analysis, or a laboratory can send their data to LGC Maine Standards where a technical specialist will complete the data analysis and return a report within five business days.  Peer group comparison is also available upon request.

For VALIDATE^® Diabetes product details click here or call 1-800-377-9684.

¹ LGC Maine Standards is the brand name for Maine Standards Company, LLC, and an entity of LGC Clinical Diagnostics Division.

About LGC Clinical Diagnostics

LGC's Clinical Diagnostics Division develops and manufactures a comprehensive portfolio of catalog and custom-developed diagnostic quality solutions and component materials for the extended life sciences industry. We partner with IVD assay developers, and pharmaceutical, CRO and academic institutions in commercialization activities across the entire diagnostic pipeline - from concept and early stage research, through expedited product development and onwards into routine clinical use. Laboratorians and diagnostic professionals across disciplines of clinical chemistry, immunochemistry, serology, molecular diagnostics and clinical genomics rely on LGC's products to support accurate and reliable diagnostic results.

Our operating entities include SeraCare Life Sciences and Maine Standards Company, which are in vitro diagnostics (IVD) manufacturers of quality measurement tools (calibrators, controls, linearity, EQA/PT, biological materials) and The Native Antigen Company, which is a manufacturer and supplier of viral antigens. Our 300+ employees operate FDA-registered and ISO 13485-accredited facilities in Maine, Massachusetts and Maryland, USA, and an ISO 9001-accredited facility in Oxford, UK.  

Each day, our world-class staff, scientific expertise, operational efficiency and superior quality systems are ready to support the range of advanced technologies that collectively improve patient outcomes - from the widely adopted and established through to cutting-edge NGS and precision diagnostics.

SOURCE LGC Maine Standards

Related Links

https://www.mainestandards.com/

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED